Presentations

Presentations

Date	Title
Nov 19, 2019	Phosphatidylserine suppresses T cells through GPR174, and co-inhibition of adenosine receptors and GPR174 synergistically enhances T cell responses 780 KB
Sep 10, 2019	Corporate Presentation 7.3 MB

OMIDRIA Manuscripts

Date	Title	Citation	Author
2/18	Effect of Phenylephrine/Ketorolac on Iris Fixation Ring Use and Surgical Times in Patients at Risk of Intraoperative Miosis	Clin Ophthalmol. 2018;12:301-305	Visco
12/17	Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery	Clin Ophthalmol. 2018;12:21-28	Rosenberg
8/17	Effect of Early Phenylephrine and Ketorolac Injection 1%/0.3% (Omidria ®) Usage on Pupil Diameter in Traditional and Femto-Assisted Cataract Surgery	Abstract with Poster presentation at: 15th International Congress on Vision Science and Eye	Gayton
10/17	Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration	Clin Ophthalmol. 2017:11 1897–1901	Katsev
	Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model	JOPT. 2018; 34:154-160	Waterbury
6/17	Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery	JCRS 2017; 43: 597-605	Donnenfeld
6/17	Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery	Clin Ophthalmol. 2017; 11: 1039-1043	Bucci
5/17	Importance of pupil dilation for cataract surgery	JCRS Editorial; Volume 43 Issue 5 May 2017	Mammalis
12/16	Letter to the Editor: An Alternative to Topical Dosing to Deliver Drugs to Target Tissues	JOPT. 2016; 10: 1-2	Waterbury
9/16	Patient considerations in cataract surgery – the role of combined therapy using phenylephrine and ketorolac	Patient Preference and Adherence 2016; 10: 1795-1801	Gonzalez-Salinas
2/16	Becoming a Believer	February 2016 \| Cataract & Refractive Surgery Today	Walter
10/15	Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies	J Cataract Refract Surg. 2015; 41: 2060- 2068	Hovanesian
7/15	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery	Clin Ophthalmol. 2015; 9: 1249-1254	Lawuyi
4/15	Point/Counterpoint: A Disruptive Innovation or a Costly Disruption?	April 2015 \| Cataract & Refractive Surgery Today	Donnenfeld / Walter
3/15	OMS302 (phenylephrine and ketorolac injection) 1%/0.3% to maintain intraoperative pupil size and to prevent postoperative ocular pain in cataract surgery with intraocular lens replacement	Expert Rev. Ophthalmol. 2015; 10(2): 91–103	Osher
9/14	Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsification	Clin Ophthalmol. 2014; 8: 1735-1744	Lindstrom
7/14	Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions	Clin Ophthalmol. 2014; 8: 1281-1289	Grob

OMS721 Posters

Date	Meeting	Title	Author
11/17	American Society of Nephrology	Maintenance of Remission Following Completion of OMS721 Treatment in Patients with IgA Nephropathy (IGAN)	Block
10/17	European Society for Blood and Marrow Transplantation - Crash Course on Diagnosis and Treatment of Noninfectious Complications after HCT	Effective Treatment of GvHD-Associated Transplant-Associated Microangiopathy with a Novel Inhibitor of the Lectin Pathway of Complement	Caprioli
06/17	54th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress	The Effect of OMS721 on Proteinuria in Patients with IgA Nephropathy	Block
04/17	International Society of Nephrology (ISN) World Congress of Nephrology	Dose-Finding Clinical Trial of OMS721 for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS) – Stage 1 Results	Nowicki
03/17	43rd Annual Meeting of the European Society for Blood and Marrow Transplantation	Resolution of acute kidney injury secondary to TA-TMA by the anti-MASP-2 monoclonal antibody OMS721 in a pediatric HSCT recipient	Zecca
02/17	2017 Tandem Meeting of the American Society of Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research	Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA)	Khaled